NASDAQ:GNOM - Global X Genomics & Biotechnology ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $15.64 -0.18 (-1.14 %) (As of 02/23/2020 03:33 AM ET) Add Today's Range$15.58Now: $15.65▼$15.6950-Day Range$14.52MA: $15.60▼$16.3252-Week Range$11.88Now: $15.65▼$16.45Volume2,511 shsAverage Volume6,723 shsMarket Capitalization$21.12 millionP/E RatioN/ADividend Yield0.00%BetaN/A ProfileAdvanced ChartEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:GNOM Previous Symbol CUSIPN/A CIK1361103 Webhttp://www.completegenomics.com/ Phone+1-650-9432800Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares1,350,000Market Cap$21.12 million Next Earnings DateN/A OptionableNot Optionable Receive GNOM News and Ratings via Email Sign-up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:GNOM Rates by TradingView Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Frequently Asked Questions What is Global X Genomics & Biotechnology ETF's stock symbol? Global X Genomics & Biotechnology ETF trades on the NASDAQ under the ticker symbol "GNOM." Has Global X Genomics & Biotechnology ETF been receiving favorable news coverage? News coverage about GNOM stock has trended very negative recently, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Global X Genomics & Biotechnology ETF earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Global X Genomics & Biotechnology ETF. What other stocks do shareholders of Global X Genomics & Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Revance Therapeutics (RVNC), Evolus (EOLS), Genomic Health (GHDX), Merck & Co., Inc. (MRK), Caci International (CACI), AbbVie (ABBV), Juno Therapeutics (JUNO) and Editas Medicine (EDIT). Who are Global X Genomics & Biotechnology ETF's major shareholders? Global X Genomics & Biotechnology ETF's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Jane Street Group LLC (2.35%) and UBS Group AG (0.26%). Which institutional investors are buying Global X Genomics & Biotechnology ETF stock? GNOM stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC and UBS Group AG. How do I buy shares of Global X Genomics & Biotechnology ETF? Shares of GNOM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Global X Genomics & Biotechnology ETF's stock price today? One share of GNOM stock can currently be purchased for approximately $15.65. How big of a company is Global X Genomics & Biotechnology ETF? Global X Genomics & Biotechnology ETF has a market capitalization of $21.12 million. View Additional Information About Global X Genomics & Biotechnology ETF. What is Global X Genomics & Biotechnology ETF's official website? The official website for Global X Genomics & Biotechnology ETF is http://www.completegenomics.com/. How can I contact Global X Genomics & Biotechnology ETF? Global X Genomics & Biotechnology ETF's mailing address is 2071 Stierlin Ct, MOUNTAIN VIEW, CA 94043-4655, United States. The company can be reached via phone at +1-650-9432800. MarketBeat Community Rating for Global X Genomics & Biotechnology ETF (NASDAQ GNOM)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 165 (Vote Outperform)Underperform Votes: 164 (Vote Underperform)Total Votes: 329MarketBeat's community ratings are surveys of what our community members think about Global X Genomics & Biotechnology ETF and other stocks. Vote "Outperform" if you believe GNOM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNOM will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2020 by MarketBeat.com StaffFeatured Article: How to calculate compound interest
